Impact of patient’s gut microbiome on clinical reponse to cancer immunotherapy


Session type:


Robert Jenq1
1University of Texas MD Anderson Cancer Center


Recent studies have examined if a relationship could exist between intestinal bacteria and the efficacy and toxicity of cancer immunotherapies, looking at the gut microbiome in patients and correlating these profiles with response and toxicity outcomes.